|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Al-Hajj M, Becker MW, Wichal M, Weissman I
and Clarke MF: Therapeutic implications of cancer stem cells. Curr
Opin Genet Dev. 14:43–47. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morrison SJ, Wandycz AM, Hemmati HD,
Wright DE and Weissman IL: Identification of a lineage of
multipotent hematopoietic progenitors. Development. 124:1929–1939.
1997.PubMed/NCBI
|
|
4
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ruben GC: The iso-competition point, a new
concept for characterizing multivalent versus monovalent counterion
competition, successfully describes cation binding to DNA. Biophys
J. 77:1–2. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mitani M, Yamanishi T, Miyazaki Y and
Ōtake N: Salinomycin effects on mitochondrial ion translocation and
respiration. Antimicrob Agents Chemother. 9:655–660. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Daugschies A, Gässlein U and Rommel M:
Comparative efficacy of anticoccidials under the conditions of
commercial broiler production and in battery trials. Veterinary
Parasitology. 76:163–171. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou S, Wang F, Wong ET, Fonkem E, Hsieh
TC, Wu JM and Wu E: Salinomycin: A novel anti-cancer agent with
known anti-coccidial activities. Curr Med Chem. 20:4095–4101. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Antoszczak M and Huczyński A: Anticancer
activity of polyether ionophore-salinomycin. Anticancer Agents Med
Chem. 15:575–591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huczynski A: Salinomycin: A new cancer
drug candidate. Chem Biol Drug Des. 79:235–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caldwell GW, Ritchie DM, Masucci JA,
Hageman W and Yan Z: The new pre-preclinical paradigm: Compound
optimization in early and late phase drug discovery. Curr Top Med
Chem. 1:353–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hartmann T, Schmitt J, Röhring C, Nimptsch
D, Nöller J and Mohr C: ADME related profiling in 96 and 384 well
plate format-a novel and robust HT-assay for the determination of
lipophilicity and serum albumin binding. Curr Drug Deliv.
3:181–192. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Di L, Kerns EH, Li SQ and Petusky SL: High
throughput microsomal stability assay for insoluble compounds. Int
J Pharm. 317:54–60. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dewangan J, Srivastava S and Rath SK:
Salinomycin: A new paradigm in cancer therapy. Tumor Biol.
39:10104283176950352017. View Article : Google Scholar
|
|
16
|
Savjani KT, Gajjar AK and Savjani JK: Drug
solubility: Importance and enhancement techniques. ISRN Pharm.
2012:1957272012.PubMed/NCBI
|
|
17
|
Fasinu P, Pillay V, Ndesendo VMK, du Toit
LC and Choonara YE: Diverse approaches for the enhancement of oral
drug bioavailability. Biopharm Drug Dispos. 32:185–209. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Patel SG, Sayers EJ, He L, Narayan R,
Williams TL, Mills EM, Allemann RK, Luk LYP, Jones AT and Tsai YH:
Cell-penetrating peptide sequence and modification dependent uptake
and subcellular distribution of green florescent protein in
different cell lines. Sci Rep. 9:62982019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Löwik DW, Meijer JT, Minten IJ, van
Kalkeren H, Heckenmüller L, Schulten I, Sliepen K, Smittenaar P and
van Hest JC: Controlled disassembly of peptide amphiphile fibres. J
Pept Sci. 14:127–133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Borrelli A, Tornesello A, Tornesello M and
Buonaguro F: Cell penetrating peptides as molecular carriers for
anti-cancer agents. Molecules. 23:E2952018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gallego I, Rioboo A, Reina JJ, Díaz B,
Canales Á, Cañada FJ, Guerra-Varela J, Sánchez L and Montenegro J:
Glycosylated cell-penetrating peptides (GCPPs). ChemBioChem.
20:1400–1409. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abramova TV and Silnikov VN:
4-Aminometyl-3-nitrobenzoic acid-a photocleavable linker for
oligonucleotides containing combinatorial libraries. Nucleosides
Nucleotides Nucleic Acids. 24:1333–1343. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kolb HC, Finn MG and Sharpless KB: Click
chemistry: Diverse chemical function from a few good reactions.
Angew Chem Int Ed Engl. 40:2004–2021. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sharpless KB and Kolb HC: Click chemistry
A concept for merging process and discovery chemistry. Abstr Pap Am
Chem Soc. 217:U95–U. 1999.
|
|
25
|
Huang X, Craita C, Awad L and Vogel P:
Silyl methallylsulfinates: Efficient and powerful agents for the
chemoselective silylation of alcohols, polyols, phenols and
carboxylic acids. Chem Commun (Camb). 1297–1299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levy DE and Tang C: The Chemistry of
C-glycosides. Elsevier; 1995
|
|
27
|
Amblard M, Fehrentz JA, Martinez J and
Subra G: Methods and protocols of modern solid phase peptide
synthesis. Mol Biotechnol. 33:239–254. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Henslee EA, Torcal Serrano RM, Labeed FH,
Jabr RI, Fry CH, Hughes MP and Hoettges KF: Accurate quantification
of apoptosis progression and toxicity using a dielectrophoretic
approach. Analyst. 141:6408–6415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vogel P and Awad LK: Disaccharide mimics
as drugs against cancer and epitopes for anti-cancer vaccine
candidates. Immun Res. 12:572016.
|
|
30
|
Awad L, Madani R, Gillig A, Kolympadi M,
Philgren M, Muhs A, Gérard C and Vogel P: A C-linked disaccharide
analogue of thomsen-friedenreich epitope induces a strong immune
response in mice. Chemistry. 18:8578–8582. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vogel P, Gerber-Lemaire S, Awad L, Bello
C, Fiaux H, Juillerat-Jeanneret L, Gillig A and Kolympadi M; CARB
29-C-Disaccharides and Analogs, : The Search for Anticancer Agents.
Amer Chemical Soc; Washington, DC: pp. 493. 2007
|
|
32
|
Awad L, Demange R, Zhu YH and Vogel P: The
use of levoglucosenone and isolevoglucosenone as templates for the
construction of C-linked disaccharides. Carbohydr Res.
341:1235–1252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Awad L, Riedner J and Vogel P: C-linked
disaccharide analogue of the Thomsen-Friedenreich (T)-epitope
alpha-O-conjugated to L-serine. Chemistry. 11:3565–3573. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Awad L: Synthesis of a C-linked
disaccharide analogue of the Thomsen Friedenreich (TF)-epitope
a-O-conjugated to L-serine and formation of a cluster as potential
anticancer vaccine. 2005.
|
|
35
|
Loay A: Synthesis of a C-linked
disaccharide analogue of the Thomsen Friedenreich (TF)-epitope
α-O-conjugated to l-serine and formation of a cluster as potential
anticancer vaccine. École Polytechnique Fédérale De Lausanne.
2005.
|
|
36
|
Demange R, Awad L and Vogel P: Synthesis
of C-linked analogues of
β-d-galactopyranosyl-(1→3)-d-galactopyranosides and of
β-d-galactopyranosyl-(1→3)-d-galactal. Tetrahedron: Asymmetry.
15:3573–3585. 2004. View Article : Google Scholar
|
|
37
|
Awad L: Synthesis of C-linked and
glycopeptide towards non-hydrozable T epitopes and artificial
Anticancer Vaccines. DEA. 2001.
|
|
38
|
Hallinan EA, Kramer SW, Houdek SC, Moore
WM, Jerome GM, Spangler DP, Stevens AM, Shieh HS, Manning PT and
Pitzele BS: 4-Fluorinated L-lysine analogs as selective i-NOS
inhibitors: Methodology for introducing fluorine into the lysine
side chain. Org Biomol Chem. 1:3527–3534. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hansen PR: Antimicrobial peptides. Methods
Mol Biol. Humana Press; New York, NY: 2017, View Article : Google Scholar
|
|
40
|
Lécaillon J, Gilles P, Subra G, Martinez J
and Amblard M: Synthesis of cyclic peptides via O-N-acyl migration.
Tetrahedron Lett. 49:4674–4676. 2008. View Article : Google Scholar
|
|
41
|
Awad L, Jejelava N, Burai R and Lashuel
HA: A new caged-glutamine derivative as a tool to control the
assembly of glutamine-containing amyloidogenic peptides.
ChemBioChem. 17:2353–2360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Butterfield S, Hejjaoui M, Fauvet B, Awad
L and Lashuel HA: Chemical strategies for controlling protein
folding and elucidating the molecular mechanisms of amyloid
formation and toxicity. J Mol Biol. 421:204–236. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Awad L, Jejelava N, Brik A and Lashuel H:
Novel chemical tools to facilitate the synthesis and control the
folding and Self-assembly of amyloid-forming polypeptides.
Biopolymers. 2011.
|
|
44
|
Klán P, Šolomek T, Bochet CG, Blanc A,
Givens R, Rubina M, Popik V, Kostikov A and Wirz J: Photoremovable
protecting groups in chemistry and biology: Reaction mechanisms and
efficacy. Chem Rev. 113:119–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Greene TW and Wuts PG: Protective groups
in organic synthesis. Wiley; 1999, View Article : Google Scholar
|
|
46
|
Borgström B, Huang X, Pošta M, Hegardt C,
Oredsson S and Strand D: Synthetic modification of salinomycin:
Selective O-acylation and biological evaluation. Chem Commun
(Camb). 49:9944–9946. 2013. View Article : Google Scholar : PubMed/NCBI
|
